ha 1004 has been researched along with Alloxan Diabetes in 1 studies
N-(2-guanidinoethyl)-5-isoquinolinesulfonamide: structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hermenegildo, C | 1 |
| Felipo, V | 1 |
| Miñana, MD | 1 |
| Grisolía, S | 1 |
1 other study available for ha 1004 and Alloxan Diabetes
| Article | Year |
|---|---|
Inhibition of protein kinase C restores Na+,K(+)-ATPase activity in sciatic nerve of diabetic mice.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Diabetes Mellitus, Experimental; Dose-Respon | 1992 |